CNPY4

CNPY4 (PRAT4B) is a Saposin-like protein that regulates membrane composition and the trafficking of signaling receptors (PMID:35504891). As an ER-associated chaperone it controls the subcellular trafficking of Toll-like receptors: it associates selectively with the immature, hypoglycosylated form of TLR4 and is required for normal cell-surface TLR4 expression (PMID:16338228), while acting as a negative regulator of TLR1 surface trafficking, since its knockdown rescues surface expression of a trafficking-deficient TLR1 variant (PMID:22447933). CNPY4 also acts as a negative regulator of Hedgehog signaling by limiting levels of accessible membrane sterol lipids including cholesterol; its loss hyperactivates Hedgehog signaling and elevates plasma membrane cholesterol, and Cnpy4 knockout embryos show digit-number defects consistent with Hedgehog perturbation (PMID:35504891). Mechanistically, this lipid control reflects a direct sphingolipid-chaperone activity: CNPY4 binds ceramide and sphingomyelin, and its depletion raises plasma membrane sphingomyelin, disrupts ceramide localization, alters neutral sphingomyelinase activity, and broadly remodels the cellular lipidome, thereby coupling sphingolipid homeostasis to cholesterol distribution and downstream signaling (PMID:41279395).

1. 2005 Medium

   Established that CNPY4/PRAT4B participates in receptor trafficking by linking it physically to an immature receptor pool and to surface receptor levels.

   Evidence Co-immunoprecipitation with immature TLR4 plus siRNA knockdown and flow cytometry in HEK293 cells

   PMID:16338228

   Open questions at the time

   • Did not define the molecular basis of CNPY4 binding to immature TLR4
   • Whether CNPY4 acts directly in the ER or at another trafficking step was not resolved
   • No structural or domain-level characterization of the interaction
2. 2012 Medium

   Showed that CNPY4 can act as a negative trafficking regulator, contrasting with the positive regulator PRAT4A and revealing receptor-specific, directionally opposite roles.

   Evidence siRNA knockdown and overexpression with TLR1 deletion/point mutant analysis and flow cytometry

   PMID:22447933

   Open questions at the time

   • Mechanism by which CNPY4 restrains TLR1 surface delivery not defined
   • Whether the same activity governs other TLRs untested
   • No reconciliation of positive (TLR4) vs negative (TLR1) trafficking roles
3. 2022 High

   Connected CNPY4 to a developmental signaling pathway and to membrane lipid control, identifying it as a negative Hedgehog regulator acting through accessible sterol levels.

   Evidence Cnpy4 knockout mouse with digit phenotype, siRNA knockdown, HH reporter assays, and filipin/membrane cholesterol measurement

   PMID:35504891

   Open questions at the time

   • Direct molecular mechanism linking CNPY4 to accessible cholesterol not fully resolved
   • Whether the Hedgehog effect is mediated by direct lipid binding was unaddressed here
   • Relationship between TLR trafficking role and sterol regulation unclear
4. 2025 Medium

   Provided a unifying biochemical mechanism: CNPY4 is a direct sphingolipid chaperone whose lipid-handling activity remodels membrane sphingolipid and sterol distribution.

   Evidence In vitro lipid-binding assays, siRNA knockdown, lipidomics, filipin staining, and sphingomyelinase activity assays (preprint)

   PMID:41279395

   Open questions at the time

   • Preprint not yet peer-reviewed
   • Structural basis of ceramide/sphingomyelin binding not determined
   • Causal chain from sphingolipid binding to cholesterol distribution and signaling not fully dissected
5. 2025 Low

   Placed CNPY4 downstream of a secretory kinase, identifying it as a FAM20C phosphorylation substrate with a possible inflammatory signaling output.

   Evidence Phosphoproteomics of FAM20C gain- and loss-of-function adipocytes

   PMID:41148235

   Open questions at the time

   • No direct mutagenesis or reconstitution of the specific phosphosite
   • Functional consequence of CNPY4 phosphorylation not mechanistically established
   • Link to its chaperone/lipid functions unknown

• How CNPY4's Saposin-like lipid-binding activity mechanistically unifies receptor trafficking, sterol/sphingolipid homeostasis, and developmental signaling remains open.
• No structure of CNPY4 bound to lipid or to a receptor client
• Whether sphingolipid binding directly drives TLR trafficking and Hedgehog effects untested
• Physiological regulation of CNPY4 activity (e.g. by phosphorylation) not characterized